This whitepaper explains how to gain the benefits of pharma marketing AI — extending your ability to deliver omnichannel engagements — while working with confidence, knowing that safe and ethical practices are being followed.
The regulated nature of the healthcare sector means that we must apply AI differently to other industries. We can’t cut and paste what works for regulation-light sectors to the life sciences. But by matching AI to established procedures — and integrating it thoughtfully into existing workflows and systems — you can assemble assets with previously impossible efficiency and speed.
Key points:
- Pharma marketing AI presents a tremendous opportunity to enable omnichannel at scale.
- Generative AI enables high-volume content creation, increasing your ability to deliver more personalised HCP engagements.
- However, there are risks that AI generates biased or false information — which is unacceptable in healthcare.
- The need for accuracy at all times, and the requirement to follow good medical legal review (MLR) practices, means that healthcare companies must handle AI differently than other industries.
- Pharma needs to match AI to its established procedures — integrating it thoughtfully into existing workflows and systems.
- In this way, you can gain the benefits of pharma marketing AI in a way that fits the specific requirements of the healthcare industry.
